GAM
EW icon

Generali Asset Management’s Edwards Lifesciences EW Stock Holding History

Generali Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.03M Sell
62,795
-9,744
-13% -$803K 0.1% 185
2025
Q4 		$6.18M Buy
72,539
+32,174
+80% +$2.64M 0.13% 154
2025
Q3 		$3.14M Buy
40,365
+1,244
+3% +$97.2K 0.07% 234
2025
Q2 		$3.06M Buy
39,121
+3,732
+11% +$278K 0.07% 235
2025
Q1 		$2.56M Buy
35,389
+3,648
+11% +$261K 0.06% 271
2024
Q4 		$2.35M Buy
+31,741
New +$2.22M 0.06% 292

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Generali Asset Management's EW Position: Q1 2026 in Review

Generali Asset Management reduced its Edwards Lifesciences (EW) stake by 13% in Q1 2026, selling an estimated $803K and leaving 62,795 shares worth $5.03M. The position accounts for 0.1% of the portfolio, ranked #185.

Generali Asset Management first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.18M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Generali Asset Management held 62,795 shares of Edwards Lifesciences worth $5.03M as of Q1 2026.
  • Generali Asset Management sold 9,744 Edwards Lifesciences shares in Q1 2026, an estimated $803K.
  • Edwards Lifesciences made up 0.1% of Generali Asset Management's portfolio in Q1 2026, its #185 holding.
  • Generali Asset Management first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • Generali Asset Management's Edwards Lifesciences position peaked at $6.18M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.